Alterations in manganese superoxide dismutase expression in the progression from reflux esophagitis to esophageal adenocarcinoma

Annals of Surgical Oncology

Volumn 14, Issue 7, 2007, Pages 2045-2055

  Li, Yan ^a   Wo, John M ^a   Su, Ruifeng R ^a   Ray, Mukunda B ^a   Martin, Robert C G ^a  

^a University of Louisville School of Medicine   (United States)

Author keywords

Barrett esophagus; Esophageal adenocarcinoma; Superoxide dismutase

Indexed keywords

8 HYDROXYDEOXYGUANOSINE; MANGANESE SUPEROXIDE DISMUTASE;

ANASTOMOSIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BARRETT ESOPHAGUS; CARCINOGENESIS; CELL PROLIFERATION; CONTROLLED STUDY; DISEASE COURSE; DYSPLASIA; ESOPHAGEAL ADENOCARCINOMA; ESOPHAGUS MUCOSA; HISTOPATHOLOGY; NICK END LABELING; NONHUMAN; PROTEIN EXPRESSION; RAT; REFLUX ESOPHAGITIS;

ADENOCARCINOMA; ANASTOMOSIS, SURGICAL; ANIMALS; APOPTOSIS; BARRETT ESOPHAGUS; CELL PROLIFERATION; DEOXYGUANOSINE; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; DUODENUM; EPITHELIAL CELLS; ESOPHAGEAL NEOPLASMS; ESOPHAGITIS, PEPTIC; ESOPHAGUS; IMMUNOHISTOCHEMISTRY; OXIDATIVE STRESS; PRECANCEROUS CONDITIONS; RATS; RATS, SPRAGUE-DAWLEY; SUPEROXIDE DISMUTASE;

EID: 34250904161     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-007-9387-7     Document Type: Article

References (42)

1. Nebel OT, Fornes MF, Castell DO. Symptomatic gastroesophageal reflux-incidence and precipitating factors. Am J Dig Dis 1976; 21:953-6
2. Thompson WG, Heaton KW. Heartburn and globus in apparently healthy people. Can Med J Assn 1982; 126:46-8
3. Altorki NK, Oliveria S, Schrump DS. Epidemiology and molecular biology of Barrett's adenocarcinoma. Semin Surg Oncol 1997; 13:270-80
4. Isolauri J, Luostarinen M, Isolauri E, et al. Natural course of gastroesophageal reflux disease: 17-22 year follow-up of 60 patients. Am J Gastroenterol 1997; 92:37-41
5. Cameron AJ. Barrett's esophagus: does the incidence of adenocarcinoma matter? Am J Gastroenterol 1997; 92:193-4
6. Blot WJ, Devesa SS, Kneller RW, et al. Rising incidence of adenocarcinoma of the esophagus and gastric cardia. JAMA 1991; 265:1287-9
7. Pera M, Cameron AJ, Trastek VF, et al. Increasing incidence of adenocarcinoma of the esophagus and esophagogastric junction. Gastroenterology 1993; 104:510-3
8. Farrow DC, Vaughan TL. Determinants of survival following the diagnosis of esophageal adenocarcinoma (United States). Cancer Causes Control 1996; 7:322-7
9. Katzka DA. Barrett's esophagus: surveillance and treatment. Gastroenterol Clin North Am 2002; 31:481-486
10. Jankowski JA, Wright NA, Meltzer SJ, et al. Molecular evolution of the metaplasiadysplasia-adenocarcinoma sequence in the esophagus. Am J Pathol 1999; 154:965-73
11. Whittles CE, Biddlestone LR, Burton A, et al. Apoptotic and proliferative activity in the neoplastic progression of Barrett's oesophagus: a comparative study. J Pathol 1999; 187:535-40
12. Hong MK, Laskin WB, Herman BE, et al. Expansion of the Ki-67 proliferative compartment correlates with degree of dysplasia in Barretts esophagus. Cancer 1995; 75:423-9
13. Ouatu-Lascar R, Fitzgerald RC, Triadafilopoulos G. Differentiation and proliferation in Barrett's esophagus and the effects of acid suppression. Gastroenterology 1999; 117:327-35
14. Beilstein M, Silberg D. Cellular and molecular mechanisms responsible for progression of Barrett's metaplasia to esophageal carcinoma. Gastroenterol Clin North Am 2002; 31:461-469
15. Reynolds JC, Rahimi P, Hirschl D. Barrett's esophagus: clinical characteristics. Gastroenterol Clin North Am 2002; 31:441-448
16. Wetscher GJ, Hinder PR, Bagchi D, et al. Free-radical scavengers prevent reflux esophagitis in rats. Dig Dis Sci 1995; 40:1292-6
17. Wetscher GJ, Hinder RA, Bagchi D, et al. Reflux esophagitis in humans is mediated by oxygen-derived free radicals. Am J Surg 1995; 170:552-7
18. Wetscher GJ, Hinder RA, Klingler P, et al. Reflux esophagitis in humans is a free radical event. Dis Esophagus 1997; 10:29-32
19. Hermann B, Li Y, Ray MB, et al. Association of manganese superoxide dismutase expression with progression of carcinogenesis in Barrett esophagus. Arch Surg 2005; 140:1204-9
20. Jimenez P, Piazuelo E, Sanchez MT, et al. Free radicals and antioxidant systems in reflux esophagitis and Barrett's esophagus. World J Gastroenterol 2005; 11:2697-703
21. Davies KJA. Oxidative stress, antioxidant defenses, and damage removal, repair, and replacement systems. IUBMB Life 2000; 50:279-89
22. Olyaee M, Sontag S, Salman W, et al. Mucosal reactive oxygen species production in esophagitis and Barretts esophagus. Gut 1995; 37:168-73
23. Chen XX, Yang CS. Esophageal adenocarcinoma: a review and perspectives on the mechanism of carcinogenesis and chemoprevention. Carcinogenesis 2001; 22:1119-29
24. Buttar NS, Wang KK, Leontovich O, et al. Chemoprevention of esophageal adenocarcinoma by COX-2 inhibitors in an animal model of Barrett's esophagus. Gastroenterology 2002; 122:1101-12
25. Chen XX, Ding YW, Yang GY, et al. Oxidative damage in an esophageal adenocarcinoma model with rats. Carcinogenesis 2000; 21:257-63
26. Goldstein SR, Yang GY, Curtis SK, et al. Development of esophageal metaplasia and adenocarcinoma in a rat surgical model without the use of a carcinogen. Carcinogenesis 1997; 18:2265-70
27. Goldstein SR, Yang GY, Curtis SK, et al. Development of esophageal metaplasia and adenocarcinoma in a rat surgical model without the use of a carcinogen. Carcinogenesis 1997; 18:2265-70
28. Li Y, Wo JM, Ellis S, et al. A novel external esophageal perfusion model for reflux esophageal injury. Dig Dis Sci 2006; 51:527-32
29. Ismail-Beigi F, Horton PF, Pope CE. Histological consequences of gastroesophageal reflux in man. Gastroenterology 1970; 58:163-74
30. Li Y, Wo JM, Cai L, et al. Association of metallothionein expression and lack of apoptosis with progression of carcinogenesis in Barrett's esophagus. Exp Biol Med (Maywood) 2003; 228:286-92
31. Kang YJ, Li Y, Sun X, et al. Antiapoptotic effect and inhibition of ischemia/reperfusion-induced myocardial injury in metallothionein-overexpressing transgenic mice. Am J Pathol 2003; 163:1579-86
32. Hetzel DJ, Dent J, Reed WD, et al. Healing and relapse of severe peptic esophagitis after treatment with omeprazole. Gastroenterology 1988; 95:903-12
33. Epperly MW, Kagan VE, Sikora CA, et al. Manganese superoxide dismutase plasmid/liposome (MnSOD-PL) administration protects mice from esophagitis associated with fractionated radiation. Int J Cancer 2001; 20;96:221-31
34. Stickle RL, Epperly MW, Klein E, et al. Prevention of irradiation-induced esophagitis by plasmid/liposome delivery of the human manganese superoxide dismutase transgene. Radiat Oncol Invest 1999; 7:204-17
35. Jankowski JA, Wright NA, Meltzer SJ, et al. Molecular evolution of the metaplasiadysplasia-adenocarcinoma sequence in the esophagus. Am J Pathol 1999; 154:965-73
36. Jankowski JA, Harrison RF, Perry I, et al. Barrett's metaplasia. Lancet 2000; 356:2079-85
37. Chen XX, Mikhail SS, Ding YW, et al. Effects of vitamin E and selenium supplementation on esophageal adenocarcinogenesis in a surgical model with rats. Carcinogenesis 2000; 21:1531-6
38. Xu XJ, LoCicero J, Macri E, et al. Barrett's esophagus and associated adenocarcinoma in a mouse surgical model. J Surg Res 2000; 88:120-4
39. Goldstein SR, Yang GY, Curtis SK, et al. Development of esophageal metaplasia and adenocarcinoma in a rat surgical model without the use of a carcinogen. Carcinogenesis 1997; 18:2265-70
40. Jankowski JA, Harrison RF, Perry I, et al. Barrett's metaplasia. Lancet 2000; 356:2079-85
41. Jankowski JA, Wright NA, Meltzer SJ, et al. Molecular evolution of the metaplasiadysplasia-adenocarcinoma sequence in the esophagus. Am J Pathol 1999; 154:965-73
42. Hanahan D, Weinberg RA. The hallmarks of cancer. Cell 2000; 100:57-70